Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Wolbachia 50S ribosomal subunit is the large subunit of the bacterial ribosome, composed of 23S and 5S ribosomal RNAs and approximately 31 distinct proteins. It functions as the catalytic core for peptide bond formation during protein synthesis. This subunit is essential for bacterial viability and is broadly conserved among prokaryotes. In Wolbachia, as in other bacteria, the 50S subunit is crucial for translation and is the molecular target for several antibiotic classes—including macrolides, lincosamides, and phenicols—making it a validated therapeutic target for treating Wolbachia-associated infections and for anti-filarial strategies. Structural differences in the binding pockets between bacterial and eukaryotic ribosomes allow for selective inhibition by antibacterial drugs.
Inhibition of peptide bond formation; Blockage of ribosomal translocation; Inhibition of tRNA binding; Prevention of ribosome assembly and maturation
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wolbachia 50S ribosomal subunit (None commonly used; in literature, may appear as "Wolbachia 50S" or simply "50S subunit").